Skip to main content
Erschienen in: Herz 6/2021

02.03.2021 | Original articles

Role of IL-9, IL-2RA, and IL-2RB genetic polymorphisms in coronary heart disease

verfasst von: Xianghong Chen, Xingfan Wang, Zaozhang Zhang, Yuewu Chen, Chao Wang

Erschienen in: Herz | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Coronary heart disease (CHD) is one of the leading causes of disability and death worldwide. Inflammatory cytokines play an essential role in the pathogenesis of CHD. This study aimed to detect the potential association between interleukin (IL)-9, IL-2RA, and IL-2RB variants and CHD in a Han Chinese population.

Methods

This case–control study included 499 CHD patients and 496 healthy controls. Seven single-nucleotide polymorphisms (SNPs) were genotyped to investigate the possible association between the polymorphisms and CHD risk. Interactions between SNPs and CHD risk were analyzed via multifactor dimensionality reduction (MDR).

Results

We observed an association between IL‑9 rs55692658 (OR = 1.72, p = 0.003) and increased CHD risk. Age-stratified analysis indicated that regardless of the participantsʼ age, IL‑9 rs55692658 and IL-2RB rs1573673 contributed significantly to CHD susceptibility (p < 0.05, respectively). Results showed an association between IL‑9 rs55692658 and an increased risk for CHD (OR = 2.32, p = 0.003), while IL-2RA rs12722498 was correlated with decreased susceptibility to CHD (OR = 0.54, p = 0.033) in female patients. Furthermore, IL-2RA rs12569923 was related to diabetes risk in CHD patients (OR = 1.50, p = 0.028). The MDR analysis revealed a positive interaction between the SNPs.

Conclusion

The present study demonstrated that IL‑9 rs55692658, IL-2RA rs12569923, IL-2RA rs12722498, and IL-2RB rs3218264 polymorphisms might be related to CHD. The results require validation in larger studies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Li H, Sun K, Zhao R et al (2018) Inflammatory biomarkers of coronary heart disease. Front Biosci 10:185–196CrossRef Li H, Sun K, Zhao R et al (2018) Inflammatory biomarkers of coronary heart disease. Front Biosci 10:185–196CrossRef
2.
Zurück zum Zitat Jokinen E (2015) Obesity and cardiovascular disease. Minerva Pediatr 67:25–32PubMed Jokinen E (2015) Obesity and cardiovascular disease. Minerva Pediatr 67:25–32PubMed
3.
Zurück zum Zitat Mitrokhin V, Nikitin A, Brovkina O et al (2017) Association between interleukin-6/6R gene polymorphisms and coronary artery disease in Russian population: influence of interleukin-6/6R gene polymorphisms on inflammatory markers. J Inflamm Res 10:151–160CrossRef Mitrokhin V, Nikitin A, Brovkina O et al (2017) Association between interleukin-6/6R gene polymorphisms and coronary artery disease in Russian population: influence of interleukin-6/6R gene polymorphisms on inflammatory markers. J Inflamm Res 10:151–160CrossRef
4.
Zurück zum Zitat Mirhafez SR, Zarifian A, Ebrahimi M et al (2015) Relationship between serum cytokine and growth factor concentrations and coronary artery disease. Clin Biochem 48:575–580CrossRef Mirhafez SR, Zarifian A, Ebrahimi M et al (2015) Relationship between serum cytokine and growth factor concentrations and coronary artery disease. Clin Biochem 48:575–580CrossRef
5.
Zurück zum Zitat Marenberg ME, Risch N, Berkman LF et al (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041–1046CrossRef Marenberg ME, Risch N, Berkman LF et al (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 330:1041–1046CrossRef
6.
Zurück zum Zitat Sjögren M, Almgren P, Melander O (2019) Polygenetic risk for coronary artery disease increases hospitalization burden and mortality. Int J Cardiol Heart Vasc 24:100391PubMedPubMedCentral Sjögren M, Almgren P, Melander O (2019) Polygenetic risk for coronary artery disease increases hospitalization burden and mortality. Int J Cardiol Heart Vasc 24:100391PubMedPubMedCentral
7.
Zurück zum Zitat Rojas-Zuleta WG, Sanchez E (2017) IL-9: Function, Sources, and Detection. Methods Mol Biol 1585:21–35CrossRef Rojas-Zuleta WG, Sanchez E (2017) IL-9: Function, Sources, and Detection. Methods Mol Biol 1585:21–35CrossRef
8.
Zurück zum Zitat Soussi-Gounni A, Kontolemos M, Hamid Q (2001) Role of IL‑9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 107:575–582CrossRef Soussi-Gounni A, Kontolemos M, Hamid Q (2001) Role of IL‑9 in the pathophysiology of allergic diseases. J Allergy Clin Immunol 107:575–582CrossRef
9.
Zurück zum Zitat Abdelilah S, Latifa K, Esra N et al (2001) Functional expression of IL‑9 receptor by human neutrophils from asthmatic donors: role in IL‑8 release. J Immunol 166:2768–2774CrossRef Abdelilah S, Latifa K, Esra N et al (2001) Functional expression of IL‑9 receptor by human neutrophils from asthmatic donors: role in IL‑8 release. J Immunol 166:2768–2774CrossRef
10.
Zurück zum Zitat Cappuzzello C, Di Vito L, Melchionna R et al (2011) Increase of plasma IL‑9 and decrease of plasma IL‑5, IL‑7, and IFN‑γ in patients with chronic heart failure. J Transl Med 9:28CrossRef Cappuzzello C, Di Vito L, Melchionna R et al (2011) Increase of plasma IL‑9 and decrease of plasma IL‑5, IL‑7, and IFN‑γ in patients with chronic heart failure. J Transl Med 9:28CrossRef
11.
Zurück zum Zitat Singh TP, Schön MP, Wallbrecht K et al (2013) Involvement of IL‑9 in Th17-associated inflammation and angiogenesis of psoriasis. Plos One 8:e51752CrossRef Singh TP, Schön MP, Wallbrecht K et al (2013) Involvement of IL‑9 in Th17-associated inflammation and angiogenesis of psoriasis. Plos One 8:e51752CrossRef
12.
Zurück zum Zitat Koch S, Sopel N, Finotto S (2017) Th9 and other IL-9-producing cells in allergic asthma. Semin Immunopathol 39:55–68CrossRef Koch S, Sopel N, Finotto S (2017) Th9 and other IL-9-producing cells in allergic asthma. Semin Immunopathol 39:55–68CrossRef
13.
Zurück zum Zitat Zhang W, Tang T, Nie D et al (2015) IL‑9 aggravates the development of atherosclerosis in ApoE-/-mice. Cardiovasc Res 106:453–464CrossRef Zhang W, Tang T, Nie D et al (2015) IL‑9 aggravates the development of atherosclerosis in ApoE-/-mice. Cardiovasc Res 106:453–464CrossRef
14.
Zurück zum Zitat Gregersen I, Skjelland M, Holm S et al (2013) Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis. Plos One 8:e72769CrossRef Gregersen I, Skjelland M, Holm S et al (2013) Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis. Plos One 8:e72769CrossRef
15.
Zurück zum Zitat Min X, Lu M, Tu S et al (2017) Serum cytokine profile in relation to the severity of coronary artery disease. Biomed Res Int 2017:4013685PubMedPubMedCentral Min X, Lu M, Tu S et al (2017) Serum cytokine profile in relation to the severity of coronary artery disease. Biomed Res Int 2017:4013685PubMedPubMedCentral
16.
Zurück zum Zitat Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007–1008CrossRef Morgan DA, Ruscetti FW, Gallo R (1976) Selective in vitro growth of T lymphocytes from normal human bone marrows. Science 193:1007–1008CrossRef
17.
Zurück zum Zitat Ruyssen-Witrand A, Lukas C, Nigon D et al (2014) Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts). Joint Bone Spine 81:228–234CrossRef Ruyssen-Witrand A, Lukas C, Nigon D et al (2014) Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts). Joint Bone Spine 81:228–234CrossRef
18.
Zurück zum Zitat Sharfe N, Dadi HK, Shahar M et al (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin‑2 receptor. Proc Natl Acad Sci USA 94:3168–3171CrossRef Sharfe N, Dadi HK, Shahar M et al (1997) Human immune disorder arising from mutation of the alpha chain of the interleukin‑2 receptor. Proc Natl Acad Sci USA 94:3168–3171CrossRef
19.
Zurück zum Zitat Willerford DM, Chen J, Ferry JA et al (1995) Interleukin‑2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521–530CrossRef Willerford DM, Chen J, Ferry JA et al (1995) Interleukin‑2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521–530CrossRef
20.
Zurück zum Zitat Sakamoto A, Ishizaka N, Saito K et al (2012) Serum levels of IgG4 and soluble interleukin‑2 receptor in patients with coronary artery disease. Clin Chim Acta 413:577–581CrossRef Sakamoto A, Ishizaka N, Saito K et al (2012) Serum levels of IgG4 and soluble interleukin‑2 receptor in patients with coronary artery disease. Clin Chim Acta 413:577–581CrossRef
21.
Zurück zum Zitat Simon AD, Yazdani S, Wang W et al (2001) Elevated plasma levels of interleukin‑2 and soluble IL‑2 receptor in ischemic heart disease. Clin Cardiol 24:253–256CrossRef Simon AD, Yazdani S, Wang W et al (2001) Elevated plasma levels of interleukin‑2 and soluble IL‑2 receptor in ischemic heart disease. Clin Cardiol 24:253–256CrossRef
22.
Zurück zum Zitat Wadwa RP, Kinney GL, Ogden L et al (2006) Soluble interleukin‑2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 38:996–1003CrossRef Wadwa RP, Kinney GL, Ogden L et al (2006) Soluble interleukin‑2 receptor as a marker for progression of coronary artery calcification in type 1 diabetes. Int J Biochem Cell Biol 38:996–1003CrossRef
23.
Zurück zum Zitat Ding R, Gao W, Ostrodci DH et al (2013) Effect of interleukin‑2 level and genetic variants on coronary artery disease. Inflammation 36:1225–1231CrossRef Ding R, Gao W, Ostrodci DH et al (2013) Effect of interleukin‑2 level and genetic variants on coronary artery disease. Inflammation 36:1225–1231CrossRef
24.
Zurück zum Zitat Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Glob Heart 7:275–295CrossRef Thygesen K, Alpert JS, Jaffe AS et al (2012) Third universal definition of myocardial infarction. Glob Heart 7:275–295CrossRef
25.
Zurück zum Zitat Hoffman TW, van Moorsel CHM, Borie R et al (2018) Pulmonary phenotypes associated with genetic variation in telomere-related genes. Curr Opin Pulm Med 24:269–280CrossRef Hoffman TW, van Moorsel CHM, Borie R et al (2018) Pulmonary phenotypes associated with genetic variation in telomere-related genes. Curr Opin Pulm Med 24:269–280CrossRef
26.
Zurück zum Zitat Lin Y, Xue Y, Huang X et al (2018) Association between interleukin-35 polymorphisms and coronary heart disease in the Chinese Zhuang population: a case-control study. Coron Artery Dis 29:423–428CrossRef Lin Y, Xue Y, Huang X et al (2018) Association between interleukin-35 polymorphisms and coronary heart disease in the Chinese Zhuang population: a case-control study. Coron Artery Dis 29:423–428CrossRef
27.
Zurück zum Zitat Leem S, Park T (2017) An empirical fuzzy multifactor dimensionality reduction method for detecting gene-gene interactions. BMC Genomics 18:115CrossRef Leem S, Park T (2017) An empirical fuzzy multifactor dimensionality reduction method for detecting gene-gene interactions. BMC Genomics 18:115CrossRef
29.
Zurück zum Zitat Kirbis S, Breskvar UD, Sabovic M et al (2010) Inflammation markers in patients with coronary artery disease—comparison of intracoronary and systemic levels. Wien Klin Wochenschr 122(Suppl 2):31–34CrossRef Kirbis S, Breskvar UD, Sabovic M et al (2010) Inflammation markers in patients with coronary artery disease—comparison of intracoronary and systemic levels. Wien Klin Wochenschr 122(Suppl 2):31–34CrossRef
30.
Zurück zum Zitat Sun W, Han Y, Yang S et al (2020) The assessment of Interleukin-18 on the risk of coronary heart disease. Med Chem 16:626–634CrossRef Sun W, Han Y, Yang S et al (2020) The assessment of Interleukin-18 on the risk of coronary heart disease. Med Chem 16:626–634CrossRef
31.
Zurück zum Zitat Zhang T, Wang Z, Xiao W (2017) A meta-analysis of interleukin-6-572G〉C polymorphism and coronary heart disease susceptibility. Cardiol J 24:107–110CrossRef Zhang T, Wang Z, Xiao W (2017) A meta-analysis of interleukin-6-572G〉C polymorphism and coronary heart disease susceptibility. Cardiol J 24:107–110CrossRef
32.
Zurück zum Zitat Gerlach K, Weigmann B (2019) The dichotomous function of interleukin‑9 in cancer diseases. J Mol Med 97:1377–1383CrossRef Gerlach K, Weigmann B (2019) The dichotomous function of interleukin‑9 in cancer diseases. J Mol Med 97:1377–1383CrossRef
33.
Zurück zum Zitat Khamis RY, Ammari T, Mikhail GW (2016) Gender differences in coronary heart disease. Heart 102:1142–1149CrossRef Khamis RY, Ammari T, Mikhail GW (2016) Gender differences in coronary heart disease. Heart 102:1142–1149CrossRef
34.
Zurück zum Zitat Rizos I, Tsiodras S, Rigopoulos AG et al (2007) Interleukin‑2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome. Cytokine 40:157–164CrossRef Rizos I, Tsiodras S, Rigopoulos AG et al (2007) Interleukin‑2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome. Cytokine 40:157–164CrossRef
35.
Zurück zum Zitat Liao W, Lin JX, Leonard WJ (2011) IL‑2 family cytokines: new insights into the complex roles of IL‑2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23:598–604CrossRef Liao W, Lin JX, Leonard WJ (2011) IL‑2 family cytokines: new insights into the complex roles of IL‑2 as a broad regulator of T helper cell differentiation. Curr Opin Immunol 23:598–604CrossRef
36.
Zurück zum Zitat Azenabor AA, Hoffman-Goetz L (2001) 17 beta-estradiol increases Ca(2+) influx and down regulates interleukin‑2 receptor in mouse thymocytes. Biochem Biophys Res Commun 281:277–281CrossRef Azenabor AA, Hoffman-Goetz L (2001) 17 beta-estradiol increases Ca(2+) influx and down regulates interleukin‑2 receptor in mouse thymocytes. Biochem Biophys Res Commun 281:277–281CrossRef
37.
Zurück zum Zitat McMurray RW, Ndebele K, Hardy KJ et al (2001) 17-beta-estradiol suppresses IL‑2 and IL‑2 receptor. Cytokine 14:324–333CrossRef McMurray RW, Ndebele K, Hardy KJ et al (2001) 17-beta-estradiol suppresses IL‑2 and IL‑2 receptor. Cytokine 14:324–333CrossRef
38.
Zurück zum Zitat Vedin O, Hagström E, Östlund O et al (2017) Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease. Int J Cardiol 245:271–276CrossRef Vedin O, Hagström E, Östlund O et al (2017) Associations between tooth loss and prognostic biomarkers and the risk for cardiovascular events in patients with stable coronary heart disease. Int J Cardiol 245:271–276CrossRef
39.
Zurück zum Zitat Reunanen A, Takkunen H, Knekt P et al (1982) Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl 668:49–59PubMed Reunanen A, Takkunen H, Knekt P et al (1982) Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl 668:49–59PubMed
40.
Zurück zum Zitat Zhao XC, Yang SH, Yan YQ et al (2018) Identification of differential gene expression profile from peripheral blood cells of military pilots with hypertension by RNA sequencing analysis. BMC Med Genomics 11:59CrossRef Zhao XC, Yang SH, Yan YQ et al (2018) Identification of differential gene expression profile from peripheral blood cells of military pilots with hypertension by RNA sequencing analysis. BMC Med Genomics 11:59CrossRef
41.
Zurück zum Zitat Motsinger AA, Ritchie MD, Shafer RW et al (2006) Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics 16:837–845CrossRef Motsinger AA, Ritchie MD, Shafer RW et al (2006) Multilocus genetic interactions and response to efavirenz-containing regimens: an adult AIDS clinical trials group study. Pharmacogenet Genomics 16:837–845CrossRef
Metadaten
Titel
Role of IL-9, IL-2RA, and IL-2RB genetic polymorphisms in coronary heart disease
verfasst von
Xianghong Chen
Xingfan Wang
Zaozhang Zhang
Yuewu Chen
Chao Wang
Publikationsdatum
02.03.2021
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 6/2021
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-020-05004-z

Weitere Artikel der Ausgabe 6/2021

Herz 6/2021 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.